Search
Now showing items 1-10 of 63
Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia With Venetoclax and Azacitidine
Pratz, Keith W. et al. (2022)
Wissenschaftlicher Artikel
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
Witte, Hanno M. et al. (2022)
Wissenschaftlicher Artikel
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials
Kaddu-Mulindwa, Dominic et al. (2022)
Wissenschaftlicher Artikel
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
Estey, Elihu; Hasserjian, Robert P.; Döhner, Hartmut (2022)
Wissenschaftlicher Artikel
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party
Tettero, Jesse M. et al. (2022)
Wissenschaftlicher Artikel
Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies
Witte, Hanno M.; Gebauer, Niklas; Steinestel, Konrad (2022)
Wissenschaftlicher Artikel
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Ng, Yuen Lam Dora et al. (2022)
Wissenschaftlicher Artikel
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of Concept, Phase Ib Study
Razak, Albiruni R. Abdul et al. (2022)
Wissenschaftlicher Artikel
Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2
Gagiannis, Daniel et al. (2022)
Wissenschaftlicher Artikel